AAAAAA

   
Results: 1-7 |
Results: 7
Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock
Authors: Matyal, R Vin, Y Delude, RL Lee, C Creasey, AA Fink, MP
Citation: R. Matyal et al., Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock, INTEN CAR M, 27(8), 2001, pp. 1274-1280
Tissue factor pathway inhibitor activity in severe sepsis
Authors: Creasey, AA Reinhart, K
Citation: Aa. Creasey et K. Reinhart, Tissue factor pathway inhibitor activity in severe sepsis, CRIT CARE M, 29(7), 2001, pp. S126-S129
Assessment of the safety of recombinant tissue factor pathway inhibitor inpatients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study
Authors: Abraham, E Reinhart, K Svoboda, P Seibert, A Olthoff, D Dal Nogare, A Postier, R Hempelmann, G Butler, T Martin, E Zwingelstein, C Percell, S Shu, V Leighton, A Creasey, AA
Citation: E. Abraham et al., Assessment of the safety of recombinant tissue factor pathway inhibitor inpatients with severe sepsis: A multicenter, randomized, placebo-controlled, single-blind, dose escalation study, CRIT CARE M, 29(11), 2001, pp. 2081-2089
The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis
Authors: Opal, SM Palardy, JE Parejo, NA Creasey, AA
Citation: Sm. Opal et al., The activity of tissue factor pathway inhibitor in experimental models of superantigen-induced shock and polymicrobial intra-abdominal sepsis, CRIT CARE M, 29(1), 2001, pp. 13-17
Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia
Authors: de Jonge, E Dekkers, PEP Creasey, AA Hack, CE Paulson, SK Karim, A Kesecioglu, J Levi, M van Deventer, SJH van der Poll, T
Citation: E. De Jonge et al., Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia, J INFEC DIS, 183(12), 2001, pp. 1815-1818
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Authors: de Jonge, E Dekkers, PEP Creasey, AA Hack, CE Paulson, SK Karim, A Kesecioglu, J Levi, M van Deventer, SJH van der Poll, T
Citation: E. De Jonge et al., Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia, BLOOD, 95(4), 2000, pp. 1124-1129
Effects of immune complex formation and complement activation on circulating platelets in the primate
Authors: Birmingham, DJ Hebert, LA Shen, XP Higgins, P Yeh, CG Creasey, AA
Citation: Dj. Birmingham et al., Effects of immune complex formation and complement activation on circulating platelets in the primate, CLIN IMMUNO, 91(1), 1999, pp. 99-105
Risultati: 1-7 |